Get the Stockscreener App
4.45
0.91%
0.04
Basel Medical Group Ltd stock is traded at $4.45, with a volume of 78,689.
It is up +0.91% in the last 24 hours and up +10.15% over the past month.
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.
See More
Previous Close:
$4.41
Open:
$4.4
24h Volume:
78,689
Relative Volume:
0.88
Market Cap:
$84.16M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-5.42%
1M Performance:
+10.15%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.34
$4.6283
1-Week Range:
$4.11
$4.95
52-Week Range:
$3.63
$5.50
Basel Medical Group Ltd Stock (BMGL) Company Profile
Name
Basel Medical Group Ltd
Sector
Industry
Phone
-
Address
-
Compare BMGL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMGL
Basel Medical Group Ltd
|
4.45 | 84.16M | 0 | 0 | 0 | 0.00 |
|
HCA
Hca Healthcare Inc
|
335.01 | 83.86B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.65 | 14.48B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
140.03 | 12.07B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
121.81 | 11.79B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
174.80 | 11.66B | 15.42B | 1.03B | 956.84M | 15.02 |
Basel Medical Group Ltd Stock (BMGL) Latest News
WORK Medical Technology Group receives Nasdaq notification - Medical Buyer
Basel Medical Group acquires Bethesda Medical - Medical Buyer
SEA Digest: Basel to buy SG's Bethesda Medical; Indonesia's Surge bags NTT East investment - DealStreetAsia
Bethesda Medical acquired by Basel Medical - Crunchbase
Basel Medical to acquire Bethesda Medical, terms undisclosed - TipRanks
Basel Medical Group Expands with Acquisition of Bethesda Medical - TipRanks
Basel Medical Group to Acquire Bethesda Medical in Southeast Asia Expansion Push - marketscreener.com
Basel Medical to buy Singapore-based Bethesda Medical - Seeking Alpha
Basel Medical To Acquire Singapore's Bethesda Medical For Undisclosed Terms - Nasdaq
Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia - The Manila Times
Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia - GlobeNewswire Inc.
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Pre-market Movers: VERO, WORX, GFR, ALTG, QLGN… - RTTNews
Basel Medical Group Appoints Founder Raymond Fung to Board - TipRanks
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer - PR Newswire
Oscar-winning Palestinian director ‘attacked by Israeli settlers and detained’ - North Wales Chronicle
Palestinian Director of 'No Other Land' Attacked by Settler Mob, Arrested by Soldiers, Israeli Co-director Says - Haaretz
Basel Medical Group Completes Overallotment Option Exercise in IPO - TipRanks
Basel Medical Group Ltd Announces Exercise of Overallotment Option - The Manila Times
Orchid Island Capital Announces March 2025 Monthly Dividend and February 28, 2025 RMBS Portfolio Characteristics - The Manila Times
Basel Medical Group Ltd Completes Full Exercise of Overallotment Option in IPO, Raising Additional $1.32 Million - Nasdaq
Novartis is watching US reciprocal tariff policy 'very carefully', CEO says - Reuters
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates - TradingView
Roche secures Zealand obesity drug candidate for up to $5.3 billion - Reuters
Med-tech sector starts strong, with $6.28B in 2025 financings - BioWorld MedTech
Kestra Medical stock surges on public debut (KMTS:NASDAQ) - Seeking Alpha
Basel Medical prices $8.8M IPO - BioWorld Online
Basel Medical Group Ltd Completes $8.82 Million IPO - TipRanks
Mahindra Launches two Electric Origin SUVs, the BE 6 & the XEV 9e for India, Available with Monroe Intelligent Suspension Technology - The Manila Times
Basel Medical Group Ltd Closes $8.82 Million Initial Public Offering on Nasdaq - Nasdaq
Phase III study shows Xolair may be more effective with fewer side effects than oral immunotherapy for the treatment of food allergies - Yahoo Finance
U.S. IPO Weekly Recap: Small Asia-Based Names List, As TV Adtech MNTN And Others Join The Pipeline - Seeking Alpha
Basel Medical Group Ltd Launches $8.82 Million IPO on Nasdaq - TipRanks
Basel Medical Group stock edges up 4% following U.S. IPO - MSN
Basel Medical Group Prices IPO At $4.00 Per Share, Raising $8.82Mln; Stock Down - Nasdaq
Basel Medical Group Prices US $8,820,000 Initial Public Offering - TradingView
Basel Medical prices IPO of over 2 million shares at $4.00 per share - Investing.com India
Why Basel Medical Group Ltd (NASDAQ:BMGL) Looks Like A Quality Company - Yahoo Finance
Basel Medical Prices IPO at $4.00-$5.00 Per Share (BMGL) - Defense World
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting—lessons from the MACUSTAR study | Eye - Nature
Roche Group's total sales 2006-2024 - Statista
Opening Day: LNG player Venture Global opens below reduced IPO price - TipRanks
Opening Day: Oilfield services provider Flowco jumps in market debut - Yahoo Finance
Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report - Pharmafile
Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech
Layoffs Continued Across Biopharma in 2024 - BioSpace
Coffee consumption and adverse cardiovascular events in patients with atrial fibrillation - BMC Medicine
Johnson & Johnson in Switzerland - Johnson & Johnson
(PDF) Trust in the health care professional and health outcome: A meta-analysis - ResearchGate
Opening Day: Jinxin Technology, zSpace make public debut - Nasdaq
Basel Medical Group Ltd Stock (BMGL) Financials Data
There is no financial data for Basel Medical Group Ltd (BMGL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.16%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):